![European American Chamber of Commerce New York [EACCNY] | Your Partner for Transatlantic Business Resources](https://eaccny.com/wp-content/uploads/2020/06/eaccny-logo.png){kind=logo}
Brexit News
Brexit News
18
Jan
VULCAN VIEW- KEY EVENTS THIS WEEK:
AfD decides on party strategy for EU electionsDuring a special AfD party convention last weekend in which the party decided on its campaign and strategic goals for the upcoming EU election in May of this year, hardliners demanded the immediate exit of Germany from the EU. Calling for “Dexit” did not gain enough momentum within the party. A proposed exit by 2024 ended up being watered down as party leader Alexander Gauland said leaving the...
18
Jan
By Sam Natapoff, President of Empire Global Ventures LLC
Confused by what just happened with Brexit and what happens next? You're not alone. Here's the way forward
At 7pm Tuesday night in London, UK Prime Minister Theresa May lost a 432-202 vote in the House of Commons, on the Brexit deal she had personally negotiated. 118 MPs from her Conservative party voted against her, sending her to the worst defeat of any Prime Minister in Britain’s modern era and the worst rebellion in the history of...
17
Jan
In the debate following the UK House of Commons’ meaningful vote, MEPs underlined that Europeans will remain united and that citizens’ rights are still the EP’s priority.
Following the rejection of the Withdrawal Agreement and the Political Declaration in the UK’s House of Commons yesterday evening, it is now up to the UK government and UK Parliament to let the EU know where a positive majority lies and what type of relationship they want with the European Union, MEPs stressed.
The...
16
Jan
Commission launches debate on a gradual transition to more efficient and democratic decision-making in EU tax policy
EU tax policy
The Commission has today kick-started the debate on reforming decision-making for areas of EU taxation policy, which currently requires unanimity among Member States. This unanimity often cannot be achieved on crucial tax initiatives, and can lead to costly delays on sub-optimal policies. The Communication published today suggests a roadmap for a progressive and targeted transition to qualified majority voting under the ordinary legislative...
16
Jan
Strasbourg, 16 January 2019
By Frans Timmermans & Michel Barnier
First Vice-President Frans Timmermans
Thank you very much, Mr President.
The vote last night in the House of Commons was crystal clear. The Withdrawal Agreement has been rejected. And now we will have to look for a way forward.
The Commission regrets the rejection of the Withdrawal Agreement, as the representative of the Council said, because we do believe this was the best possible outcome. In a situation where two parties were negotiating, looking after their...
15
Jan
By Lucinda Creighton, CEO & Robert O’Reilly, Strategic Counsel | Vulcan Consulting
Situation Analysis
Today’s vote presents yet another “crunch moment” in the long running Brexit saga. For those who have not been following in any great detail, this is Prime Minister Theresa May’s big moment in the House of Commons, when she will attempt to get the deal she has agreed with the European Union through by way of parliamentary vote. This so called ‘Exit Deal’ does not set out the...
11
Jan
VULCAN VIEW - KEY EVENTS THIS WEEK:
European Union:
The Polish and Italian Election Coalition
With the European Elections in full swing, the leaders of the most popular populist parties in Poland and Italy will meet Wednesday to discuss a common strategy for the Elections in May. Matteo Salvini and Jarosław Kaczyński (PiS) are hoping that the common ground they have concerning migration and their euroskepticism, will enable a joint position in the next election. However, they have very different views on Russia.
PiS,...
09
Jan
By Evelyn Schulz & Susann Jahn | Noerr
Following our article “Brexit with or without a deal: Consequences for pharmaceutical companies”, which provided a general overview of the challenges facing pharmaceutical companies, this article deals specifically with the impact of Brexit on medicinal product marketing authorisations.
Whether there will be a Brexit with or without a deal is of secondary importance with regard to medicinal product marketing authorisations – this question primarily determines the period within which pharmaceutical companies will be confronted with the...
Other Chapter News
